A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial To Evaluate The Efficacy And Safety Of A Respiratory Syncytial Virus (Rsv) Prefusion F Subunit Vaccine In Infants Born To Women Vaccinated During Pregnancy

  • Buttery, Jim (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 64789
NMA SSA Reference Number: SSA/64789/MonH-2020-229382(v1)
Monash Health Reference: RES-20-0000-351A
StatusActive
Effective start/end date1/09/20 → 31/08/25

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • treatment safety